(PharmaNewsWire.Com, February 22, 2018 ) The Global Antibody Drug Conjugates Market was worth USD 6.1 billion in 2017 and estimated to be growing at a CAGR of 24.5%, to reach USD 18.25 billion by 2022. Antibody drug conjugate (ADC) is a biologically active drug used as targeted therapy in the treatment of cancer that is highly potent drugs of biopharmaceutical industry. These drugs are chemically complex molecules intended to kill the cancer cells in the body which composed of antibody that is biologically linked to anticancer drugs. These drugs target multiple pathways and reduces the risk of developing treatment resistant disorders in the body.
By the mechanism of action, the drugs are segmented into IgG1 antibodies and HER2 antibodies which affect different pathogens like bacteria, fungi and virus in the body. Antibody drug conjugates are widely accepting by several small and big pharmaceutical companies that is filling gaps between many oncology product pipelines. These drugs are also used in many other applications like metabolic disorders, cardiovascular, central nervous system, life science research tools, medical imaging and vaccines.
Factors like rise in cancer incidences, changing lifestyles, high investments by the companies in the pipeline analysis, cancer killing ability and research development of ADCs, growing biomedical industry, new product innovations and technology advancements are driving the Global Antibody Drug Conjugates Market. However, high cost of production of ADCs and stringent regulations for the product approval are hindering the growth of the market.
The Global Antibody Drug Conjugates Market is segmented on the basis of pipeline analysis, end-user and region. Based on the pipeline analysis, the market is segmented into phase, mode of action, technology and linker. The mode of action segment is sub-segmented into IgG1 antibodies and HER2 antibodies. The technology segment is further segmented into Seattle genetics, Immunogen and Immunomedics. On the basis of End-user, the market is segmented into research institutes, hospitals, clinics and others. The market has also been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is dominating the global market due to the presence of large companies in this area and their high investment in the cancer product pipelines. Asia-Pacific is the fastest growing region with a high CAGR owing to the rise in prevalence of cancer and emerging economies like China and India.
Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms Technology along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
